Omeprazole 20 mg three days a week and 10 mg daily in prevention of duodenal ulcer relapse

Statistical Methods for Rates and Proportions

2003 • 17,930 citations

Statistical Methods for Rates and Proportions.

1981 • 8,945 citations

Clinical Trials: A Practical Approach.

1984 • 2,966 citations

Maximum utilization of the life table method in analyzing survival

1958 • 2,937 citations

Clinical trials: A practical approach

1984 • 1,236 citations

A computer program for comparing K samples with right-censored data

1972 • 731 citations

Substituted benzimidazoles inhibit gastric acid secretion by blocking (H+ + K+) ATPase

1981 • 619 citations

Plasma gastrin and gastric enterochromaffinlike cell activation and proliferation

1986 • 506 citations

Production and Evaluation of Antibodies for the Radioimmunoassay of Gastrin

1972 • 428 citations

Effect of Omeprazole and Ranitidine on Ulcer Healing and Relapse Rates in Patients with Benign Gastric Ulcer

1989 • 382 citations

Enterochromaffin-Like Cell Carcinoids of Gastric Mucosa in Rats after Life-Long Inhibition of Gastric Secretion

1986 • 372 citations

Histopathological Classification of Nonantral Gastric Endocrine Growths in Man

1988 • 361 citations

Texicological studies on omeprazole

1985 • 359 citations

Medical Uses of Statistics.

1989 • 305 citations

DOUBLE-BLIND MULTICENTRE COMPARISON OF OMEPRAZOLE AND RANITIDINE IN THE TREATMENT OF REFLUX OESOPHAGITIS

1987 • 282 citations

Omeprazole or Ranitidine in the Treatment of Reflux Esophagitis: Results of a Double-Blind, Randomized, Scandinavian Multicenter Study

1988 • 277 citations

Optimal dose of oral omeprazole for maximal 24 hour decrease of intragastric acidity.

1984 • 237 citations

Omeprazole and ranitidine in treatment of reflux oesophagitis: double blind comparative trial

1988 • 216 citations

Intragastric bacterial activity and nitrosation before, during, and after treatment with omeprazole.

1984 • 199 citations

Twenty‐four‐hour intragastric acidity and plasma gastrin concentration before and during treatment with either ranitidine or omeprazole

1987 • 191 citations

Effect of Omeprazole and Cimetidine on Duodenal Ulcer

1985 • 188 citations

Effect of daily oral omeprazole on 24 hour intragastric acidity.

1983 • 187 citations

The Achlorhydria-Carcinoid Sequence: Role of Gastrin

1988 • 181 citations

Long-Term Omeprazole Treatment in Man: Effects on Gastric Endocrine Cell Populations

1988 • 150 citations

Therapy with Omeprazole in Patients With Peptic Ulcerations Resistant to Extended High-Dose Ranitidine Treatment

1988 • 106 citations

Twenty‐four‐hour intragastric acidity and plasma gastrin concentration in healthy subjects and patients with duodenal or gastric ulcer, or pernicious anaemia

1987 • 93 citations

Gastric H,K-ATPASE as Therapeutic Target

1988 • 76 citations

Effects of eight weeks' continuous treatment with oral ranitidine and cimetidine on gastric acid secretion, pepsin secretion, and fasting serum gastrin.

1983 • 69 citations

Kurzzeit-Therapie des Ulcus duodeni mit Omeprazol und Ranitidin: Ergebnisse einer deutschen Multizenterstudie

2008 • 60 citations

Comparison of Ranitidine and High-Dose Antacid in the Treatment of Prepyloric or Duodenal Ulcer

1985 • 60 citations

Plasma gastrin and gastric enterochromaffinlike cell activation and proliferation

1986 • 56 citations

Enprostil and ranitidine in duodenal ulcer healing: double blind comparative trial.

1986 • 54 citations

Effect of omeprazole and cimetidine on prepyloric gastric ulcer: double blind comparative trial.

1988 • 52 citations

Antisecretory drugs and gastric cancer.

1985 • 49 citations

A simple enzymatic procedure for radioimmunochemical quantitation of the large molecular forms of gastrin and cholecystokinin

1980 • 47 citations

Acid inhibitory characteristics of omeprazole in man

1985 • 41 citations

The box-plot: An exploratory analysis graph for biomedical publications

1988 • 28 citations

Inhibition of acid and gastric carcinoids.

1985 • 26 citations

Omeprazole and cimetidine in the treatment of ulcers of the body of the stomach: a double blind comparative trial. Danish Omeprazole Study Group.

1989 • 23 citations

Antisecretory effect and oral pharmacokinetics following low dose omeprazole in man.

1985 • 23 citations

Interpretation of statistical methodology associated with maintenance trials.

1984 • 22 citations

Effects of Omeprazole in Duodenal Ulcer Patients

1986 • 21 citations

Enprostil and ranitidine in prevention of duodenal ulcer relapse: one year double blind comparative trial.

1987 • 20 citations

Effect of 10 mg and 20 mg omeprazole daily on duodenal ulcer: double‐blind comparative trial

1989 • 18 citations

Effect of 'weekend therapy' with omeprazole on basal and stimulated acid secretion and fasting plasma gastrin in duodenal ulcer patients.

1988 • 16 citations

Omeprazole inhibition of nocturnal gastric secretion in patients with duodenal ulcer.

1984 • 15 citations

Review: the enterochromaffin‐like cell, intragastric acidity and the trophic effect of plasma gastrin

1988 • 12 citations

Relapse of Gastric Ulcers after Healing with Omeprazole and Cimetidine: A Double-Blind Follow-up Study

1989 • 11 citations

Reduction of Gastric Acid Secretion by 10 Mg and 30 Mg Omeprazole Once Daily

1985 • 10 citations

Effect of intermittent weekend therapy with omeprazole on basal and postprandial serum gastrin concentrations in patients with duodenal ulcer

1988 • 9 citations

Review: clinical trials in peptic ulcer disease—problems of methodology and interpretation

1987 • 8 citations

Effect of low‐dose omeprazole on gastric acid secretion in duodenal ulcer patients

1988 • 7 citations